BCL2 and ulcerative colitis: This finding aligns with previous research conducted by Labib and colleagues [28], which demonstrated that nebivolol significantly reduces caspases 3 and increases Bcl-2 in a rat model of ulcerative colitis compared to an untreated induced group [39].